48 Weeks, Study to Evaluate Overall Safety and Tolerability of Co-administration of Tesofensine and Metoprolol in Subjects With Hypothalamic Injury-induced Obesity (HIO)
Condition: Hypothalamic Injury-induced Obesity (HIO) Interventions: Drug: Tesofensine; Drug: Placebo Sponsor: Saniona Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2019 Category: Research Source Type: clinical trials
